## ACN: Accenture plc - XLK: Technology

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 5.9% in lower entry zone (4.0-10.0%), top quartile (87th pct) cross-sectional ranking. Short-term MRS_5 (2.3%) confirms momentum alignment. Strong momentum (+5.5% 5-day acceleration). Outperforming sector by 6.1%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($254.60)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 8
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Accenture and Snowflake Drive Enterprise Reinvention with AI and Data**
- Source: Quantisnow | 20251204T150840 | Bullish | Relevance: 100%
- Accenture and Snowflake have formed the Accenture Snowflake Business Group to help global enterprises like Caterpillar accelerate AI and data transformation. This collaboration leverages Snowflake's AI Data Cloud and Accenture's industry experience, augmented by over 5,000 Accenture SnowPro-certified professionals. The initiative aims to enable companies to reinvent business models, build AI-powered applications, and enhance decision-making by harnessing cloud, AI, and data.

**2. Accenture plc Class A (Ireland) (ACN) Stock Price | Live Quotes & Charts | NYSE**
- Source: StocksToTrade | 20251203T050755 | Neutral | Relevance: 100%
- This article provides live stock price information and charts for Accenture plc Class A (Ireland) (ACN) on the NYSE. It displays the current stock price, daily change, and available charting options. The page also mentions the lack of current analyst ratings and earnings information for ACN.

**3. Accenture's CEO-EMEA sells shares valued at $354,322**
- Source: MSN | 20251202T010723 | Somewhat-Bearish | Relevance: 100%
- Julie Sweet, CEO-EMEA at Accenture, recently sold 1,114 shares of company stock at a price of $318.06 per share, totaling $354,322.24. This transaction follows other recent insider activities including sales by the Vice Chairman and CFO, and purchases by a Director and the Global CEO of the firm.

**4. Veeva AI Agents Now Available to Increase Productivity and Customer Centricity**
- Source: Sahm | 20251204T044247 | Somewhat-Bullish | Relevance: 64%
- Veeva Systems has launched Veeva AI Agents for Vault CRM and PromoMats, marking a significant step in industry-specific AI for life sciences. These agents are designed to enhance productivity, customer centricity, and compliance by seamlessly integrating with Veeva applications and providing features like issue detection, voice input, and content analysis. Additional AI Agents for other areas such as clinical, regulatory, and safety are slated for release throughout 2026.

**5. WRITER and AWS Team Up to Make Enterprise Agents More Scalable and Secure**
- Source: Business Wire | 20251202T170545 | Somewhat-Bullish | Relevance: 63%
- WRITER and AWS have teamed up to enhance the scalability and security of enterprise AI agents. This collaboration involves WRITER providing direct access to Amazon Bedrock, integrating various models, and introducing a new agent supervision and orchestration suite for better control and observability. These advancements aim to empower businesses to build and deploy AI agents with greater flexibility and security, ensuring compliance and data protection.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 50 ($3.93M) |
| Sells | 11 ($2.42M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 35.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.9% (+0.1%)
- Blackrock Inc.: 8.3% (+3.5%)
- State Street Corpora: 4.3% (+0.4%)
- Capital Internationa: 2.6% (+41.0%)
- Geode Capital Manage: 2.2% (+2.8%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +5.5% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.09 elevated, pricing in significant growth expectations. Forward P/E 18.1x stretched relative to 7% growth. Quality metrics strong (ROE 25%, ROA 11%). Balance sheet: $1.5B free cash flow. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $168.1B |
| Beta | 1.26 |
| 52W Range | $229.40 - $398.35 |
| Short Interest | 2.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.09 |
| Forward P/E | 18.1 |
| Current P/E | 19.5 |
| YoY Growth | 7.5% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 0.5% to 5.9% (+5.5% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 87th percentile. MRS_5 at 2.3% confirms short-term momentum alignment. AM_20 at 8.2% shows strong absolute momentum above own 20MA. Outperforming sector by 6.1pp, stock-specific strength. Below SMA200 (0.96x), long-term trend not supportive. MACD histogram positive (2.94), confirming momentum. Elevated volume (1.5x 20MA), institutional activity likely. OFD pattern: -MUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 5.94% (CS: 88) | Strong |
| RSI_14 | 66.4 | Neutral |
| MACD Histogram | 2.94 | Bullish |
| vs SMA20 | 1.082x | Above |
| vs SMA50 | 1.090x | Above |
| vs SMA200 | 0.957x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $269.34
- **Stop Loss:** $254.60 (5.5% risk)
- **Target:** $291.45 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 67
- **Position Value:** $18,045.78
- **Portfolio %:** 18.05%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at 15.78 indicates calm conditions but breadth at 53% suggests narrow participation. Fed policy remains neutral with 42 days to next meeting, supporting steady positioning with sector selectivity.*

### Earnings

**Next:** 2025-12-18 (Est: $3.73)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $3.72 | $3.94 | +5.9% |
| 2025Q3 | $2.97 | $3.03 | +2.0% |
| 2025Q2 | $3.32 | $3.49 | +5.0% |
| 2025Q1 | $2.81 | $2.82 | +0.2% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*